Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Acquisitions (2025)

GeneDx Holdings has reported Acquisitions over the past 1 years, most recently at -$339000.0 for Q4 2025.

  • Quarterly results put Acquisitions at -$339000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$339000.0 (changed N/A YoY), and the annual figure for FY2025 was $32.9 million, changed.
  • Acquisitions for Q4 2025 was -$339000.0 at GeneDx Holdings.
  • Over the last five years, Acquisitions for WGSWW hit a ceiling of -$339000.0 in Q4 2025 and a floor of -$339000.0 in Q4 2025.